Quick Answer
Aspira Women's Health Inc. reported Operating Income Loss of -$16.28 million for the year ending 2024.
- Aspira Women's Health Inc. showed an increase of +13.7% in Operating Income Loss from 2023 to 2024.
- This data is from Aspira Women's Health Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2025.
- XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2010: -$3.74 million | Q3 2010: -$3.60 million | Q1 2011: -$4.45 million | Q2 2011: -$5.60 million | Q3 2011: -$4.53 million | Q1 2012: -$2.16 million | Q2 2012: -$3.67 million | Q3 2012: -$2.30 million | Q1 2013: -$2.60 million | Q2 2013: -$2.12 million | Q3 2013: -$2.32 million | Q1 2014: -$4.00 million | Q2 2014: -$5.56 million | Q3 2014: -$5.59 million | Q1 2015: -$4.26 million | Q2 2015: -$4.85 million | Q3 2015: -$5.14 million | Q1 2016: -$4.90 million | Q2 2016: -$3.76 million | Q3 2016: -$3.47 million | Q1 2017: -$2.66 million | Q2 2017: -$2.35 million | Q3 2017: -$2.50 million | Q1 2018: -$2.84 million | Q2 2018: -$3.03 million | Q3 2018: -$2.64 million | Q1 2019: -$3.72 million | Q2 2019: -$4.31 million | Q3 2019: -$3.85 million | Q1 2020: -$3.80 million | Q2 2020: -$3.83 million | Q3 2020: -$4.28 million | Q1 2021: -$5.89 million | Q2 2021: -$8.07 million | Q3 2021: -$9.69 million | Q1 2022: -$9.25 million | Q2 2022: -$8.22 million | Q3 2022: -$8.58 million | Q1 2023: -$6.28 million | Q2 2023: -$4.32 million | Q3 2023: -$4.12 million | Q1 2024: -$4.71 million | Q2 2024: -$4.39 million | Q3 2024: -$3.74 million | Q1 2025: -$3.24 million | Q2 2025: -$1.81 million | Q3 2025: -$1.58 million.
- Over the full 15 years of available data (2010 to 2024), Aspira Women's Health Inc.'s Operating Income Loss has declined by 11.5%.
- Historical annual values: Fiscal year 2024: -$16.28 million | Fiscal year 2023: -$18.85 million | Fiscal year 2022: -$31.14 million | Fiscal year 2021: -$32.60 million | Fiscal year 2020: -$17.98 million | Fiscal year 2019: -$15.28 million | Fiscal year 2018: -$11.33 million | Fiscal year 2017: -$10.44 million | Fiscal year 2016: -$14.95 million | Fiscal year 2015: -$19.25 million | Fiscal year 2014: -$19.21 million | Fiscal year 2013: -$8.86 million | Fiscal year 2012: -$9.41 million | Fiscal year 2011: -$17.64 million | Fiscal year 2010: -$14.60 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: